|
Index of reports
> Cases with Cardio-Respiratory Arrest (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Slow-K (Potassium) where reactions include cardio-respiratory arrest. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Slow-K side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male, weighing 38.0 kg (83.6 pounds)
Reactions: Cardio-Respiratory Arrest, Lung Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Slow-K
Administration route: Oral
Indication: Hypokalaemia
Start date: 2012-06-06
End date: 2012-06-16
Bisoprolol Fumarate
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Aldactone
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Pimobendan
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Sitagliptin Phosphate
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2012-06-06
End date: 2012-06-16
Xarelto
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Start date: 2012-06-06
End date: 2012-06-15
Xarelto
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2012-06-06
End date: 2012-06-15
Lanirapid
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Amiodarone Hydrochloride
Administration route: Oral
Indication: Arrhythmia
Start date: 2012-06-06
End date: 2012-06-16
Diart
Administration route: Oral
Indication: Cardiac Failure
Start date: 2012-06-06
End date: 2012-06-16
Possible Slow-K side effects in male
Reported by a physician from Japan on 2012-05-02
Patient: male
Reactions: Asthma, Cardio-Respiratory Arrest, Cerebral Infarction, Atrial Thrombosis, Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Enalapril Maleate
Dosage: unk
Administration route: Oral
Start date: 2010-03-04
End date: 2012-02-02
Warfarin Sodium
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2011-04-28
End date: 2011-08-03
Warfarin Sodium
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2011-08-27
End date: 2011-09-05
Lasix
Dosage: 40 mg, unk
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2008-07-22
Warfarin Sodium
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2011-08-10
End date: 2011-08-21
Warfarin Sodium
Dosage: 3.25 mg, unk
Administration route: Oral
Start date: 2011-09-16
Slow-K
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hypokalaemia
Start date: 2010-09-16
Aspirin
Dosage: 200 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2008-07-22
Sigmart
Dosage: 15 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2008-07-22
Pulmicort
Dosage: unk
Start date: 2011-09-15
Aliskiren
Dosage: unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2010-02-18
End date: 2010-03-03
Aliskiren
Dosage: unk
Administration route: Oral
Start date: 2010-03-04
End date: 2012-02-02
Aspirin
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2011-08-10
End date: 2011-08-18
Aspirin
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2011-10-21
Lipitor
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2008-07-22
Rabeprazole Sodium
Dosage: 10 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2008-07-22
Enalapril Maleate
Dosage: unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2010-01-07
End date: 2010-03-03
Aspirin
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2011-07-28
Carvedilol
Dosage: 10 mg, unk
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2008-12-11
Allopurinol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2008-09-18
Possible Slow-K side effects in male
Reported by a physician from Japan on 2012-02-14
Patient: male
Reactions: Asthma, Cardio-Respiratory Arrest
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aspirin
Dosage: 200 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2008-07-22
Aspirin
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2011-07-28
Warfarin Sodium
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2011-04-28
End date: 2011-08-03
Rabeprazole Sodium
Dosage: 10 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2008-07-22
Carvedilol
Dosage: 10 mg, unk
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2008-12-11
Pulmicort-100
Dosage: unk
Start date: 2011-09-15
Aliskiren
Dosage: unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2010-02-18
End date: 2010-03-03
Enalapril Maleate
Dosage: unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2010-01-07
End date: 2010-03-03
Enalapril Maleate
Dosage: unk
Administration route: Oral
Start date: 2010-03-04
Aspirin
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2011-08-10
End date: 2011-08-18
Aspirin
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2011-10-21
Sigmart
Dosage: 15 mg, unk
Administration route: Oral
Indication: Prophylaxis
Start date: 2008-07-22
Allopurinol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2008-09-18
Aliskiren
Dosage: unk
Administration route: Oral
Start date: 2010-03-04
Slow-K
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hypokalaemia
Start date: 2010-09-16
Lipitor
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2008-07-22
Warfarin Sodium
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2011-08-27
End date: 2011-09-05
Warfarin Sodium
Dosage: 3.5 mg, unk
Administration route: Oral
Start date: 2011-08-10
End date: 2011-08-21
Warfarin Sodium
Dosage: 3.25 mg, unk
Administration route: Oral
Start date: 2011-09-16
Lasix
Dosage: 40 mg, unk
Administration route: Oral
Indication: Cardiac Failure Chronic
Start date: 2008-07-22
|
